Metraipolis › archive › dc_f348ce32fcc1

The challenges and opportunities of applying tumour mutational burden analysis to precision cancer medicine — Europe PMC PMID:40308330

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40308330
DOI
10.1017/pcm.2024.6
License (as archived)
solo-consultazione
Archived
2026-10-08T08:58:38.444Z
SHA-256 of the archived text
437b03e1cad8d2fe637d0950f7bde0970da6dc010ecb6997bdbae64deaf9e6b4
Stable URL of this page
https://metraipolis.com/documento/dc_f348ce32fcc1

How to cite

The challenges and opportunities of applying tumour mutational burden analysis to precision cancer medicine — Europe PMC PMID:40308330 — Europe PMC (en), https://europepmc.org/article/MED/40308330 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f348ce32fcc1 (Metraipolis archive dc_f348ce32fcc1, sha256 437b03e1cad8d2fe637d0950f7bde0970da6dc010ecb6997bdbae64deaf9e6b4)
BibTeX
@misc{dcf348ce32fcc1,
  title = {The challenges and opportunities of applying tumour mutational burden analysis to precision cancer medicine — Europe PMC PMID:40308330},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40308330},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f348ce32fcc1; sha256 437b03e1cad8d2fe637d0950f7bde0970da6dc010ecb6997bdbae64deaf9e6b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40308330. Agents can read the archived copy with the MCP tool read_document.